Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.50 |
| ▸ | CA1 | P00915 | 4/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL9619217 | 0.90 | CA1 (0.54) | CA2CA1NFKB1MAPK1CYP3A4 | |
| Bicarbonate SCHEMBL6814371 | 0.88 | CA1 (0.52) | CA2CA1NFKB1GPR84MAPK1 | |
| Acetic Acid SCHEMBL10943012 | 0.88 | CA1 (0.52) | CA2CA1NFKB1MAPK1CYP3A4 | |
| Bicarbonate SCHEMBL28065295 | 0.84 | CA1 (0.48) | CA2CA1NFKB1GPR84MAPK1 | |
| Propionic Acid SCHEMBL6633544 | 0.83 | DNM1 (0.52) | CA2CA1NFKB1GPR84MAPK1 | |
| Acetic Acid SCHEMBL27695161 | 0.82 | CA1 (0.47) | CA2CA1NFKB1GPR84MAPK1 | |
| SCHEMBL626822 | 0.82 | CA2 (0.48) | CA2CA1NFKB1MAPK1CYP3A4 | |
| Propionic Acid SCHEMBL7872948 | 0.82 | CA2 (0.47) | CA2CA1NFKB1GPR84MAPK1 | |
| Acrylic Acid SCHEMBL27681921 | 0.80 | CA1 (0.45) | CA2CA1NFKB1MAPK1CYP3A4 | |
| Phosphine SCHEMBL27975608 | 0.80 | CA2 (0.47) | CA2CA1NFKB1MAPK1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10888814-B2 | Removal of carbon dioxide from a gas stream by using aqueous ionic liquid | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2021-01-12 | — | — | US | disclosed |
| US-20130058852-A1 | REMOVAL OF CARBON DIOXIDE FROM A GAS STREAM BY USING AQUEOUS IONIC LIQUID | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2013-03-07 | — | — | US | disclosed |
| WO-2011114168-A1 | REMOVAL OF CARBON DIOXIDE FROM A GAS STREAM BY USING AQUEOUS IONIC LIQUID | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2011-09-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130058852-A1 | REMOVAL OF CARBON DIOXIDE FROM A GAS STREAM BY USING AQUEOUS IONIC LIQUID | CA2, CA9, CA4 | CA2 1/4885CA1 34/4885NFKB1 4150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.